Annual ROA
-56.03%
+18.83%+25.15%
June 1, 2024
Summary
- As of February 24, 2025, NEUP annual return on assets is -56.03%, with the most recent change of +18.83% (+25.15%) on June 1, 2024.
- During the last 3 years, NEUP annual ROA has fallen by -35.75% (-176.28%).
Performance
NEUP ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROA
-11.99%
+8.88%+42.55%
December 1, 2024
Summary
- As of February 24, 2025, NEUP quarterly return on assets is -11.99%, with the most recent change of +8.88% (+42.55%) on December 1, 2024.
- Over the past year, NEUP quarterly ROA has stayed the same.
Performance
NEUP Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
NEUP ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.1% | 0.0% |
| 3 y3 years | -176.3% | +26.8% |
| 5 y5 years | -253.3% | - |
NEUP ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +176.3% | +33.6% | at high | +209.1% |
| 5 y | 5-year | +253.3% | +33.6% | at high | +209.1% |
| alltime | all time | -1122.4% | +182.4% | at high | +209.1% |
Neuphoria Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | -11.99%(-42.5%) |
| Sep 2024 | - | -20.87%(-43.7%) |
| Jun 2024 | - | -37.06%(+1.7%) |
| Jun 2024 | -56.03%(-25.2%) | - |
| Dec 2023 | - | -36.44%(+122.6%) |
| Sep 2023 | - | -16.37% |
| Jun 2023 | -74.86%(+114.3%) | - |
| Jun 2022 | -34.93%(+72.2%) | - |
| Jun 2021 | -20.28%(+27.0%) | - |
| Jun 2020 | -15.97%(+0.7%) | - |
| Jun 2019 | -15.86%(-51.6%) | - |
| Jun 2018 | -32.79%(+311.9%) | - |
| Jun 2017 | -7.96%(-61.9%) | - |
| Jun 2016 | -20.89%(-8.2%) | - |
| Jun 2015 | -22.75%(-515.1%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | 5.48%(-124.2%) | - |
| Jun 2013 | -22.60%(+141.2%) | - |
| Jun 2012 | -9.37%(-70.3%) | - |
| Jun 2011 | -31.52%(+5.5%) | - |
| Jun 2010 | -29.87%(+26.8%) | - |
| Jun 2009 | -23.55%(+36.9%) | - |
| Jun 2008 | -17.20%(-24.1%) | - |
| Jun 2007 | -22.67%(-21.8%) | - |
| Jun 2006 | -28.99%(-3.7%) | - |
| Jun 2005 | -30.11%(+14.1%) | - |
| Jun 2004 | -26.40%(-25.0%) | - |
| Jun 2003 | -35.19%(+59.7%) | - |
| Jun 2002 | -22.03%(-27.2%) | - |
| Jun 2001 | -30.28%(+13.3%) | - |
| Jun 2000 | -26.73%(-83.1%) | - |
| Jun 1999 | -158.23% | - |
FAQ
- What is Neuphoria Therapeutics annual return on assets?
- What is the all time high annual ROA for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics annual ROA year-on-year change?
- What is Neuphoria Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics quarterly ROA year-on-year change?
What is Neuphoria Therapeutics annual return on assets?
The current annual ROA of NEUP is -56.03%
What is the all time high annual ROA for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high annual return on assets is 5.48%
What is Neuphoria Therapeutics annual ROA year-on-year change?
Over the past year, NEUP annual return on assets has changed by +18.83% (+25.15%)
What is Neuphoria Therapeutics quarterly return on assets?
The current quarterly ROA of NEUP is -11.99%
What is the all time high quarterly ROA for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high quarterly return on assets is -11.99%
What is Neuphoria Therapeutics quarterly ROA year-on-year change?
Over the past year, NEUP quarterly return on assets has changed by 0.00% (0.00%)